A B S T R A C T The plasma low density lipoproteins (LDL) in biliary obstruction are characterized almost exclusively by the presence of the immunochemically distinct lipoprotein families, lipoprotein B (LP-B) and lipoprotein X (LP-X). It is suggested that LP-X, with its uniquely high content of unesterified cholesterol and phospholipid, is primarily responsible for the unusual lipid composition of LDL and the abnormal plasma lipid composition in obstructive jaundice.
INTRODUCTION
The plasma lipoprotein pattern in subjects with biliary obstruction is characterized after ultracentrifugation by concentration of HDL (1) (2) (3) (4) . However, it has been demonstrated (5) that the characteristic elevation of plasma unesterified cholesterol and phospholipid concentrations is due to the presence of abnormal lipoproteins in Cohn fractions IV-VI which normally contain HDL or a-LP. Russ, Raymunt, and Barr (6) partially resolved these paradoxical findings by demonstrating that the lipoproteins present in Cohn fractions IV-VI had low hydrated densities (1.035-1.049 g/ml) but failed to react with antibodies to normal serum LDL. Switzer (7) established that serum LDL from patients with extrahepatic biliary obstruction contains, in addition to the usual amounts of LP-B, a high content of an abnormal lipoprotein which does not react with antibodies to normal LDL and is characterized by a low content of protein and a very high content of phospholipid and unesterified cholesterol. The immunochemical properties and the amino acid composition of this abnormal lipoprotein differ from those of LP-A and LP-B. In contrast to these studies, several investigators (8) (9) (10) demonstrated immunochemically the presence of LP-A in the LDL fraction, and Fredrickson, Levy, and Lees (11) suggested that the increased concentration of LDL in patients with biliary obstruction is caused by a shift of LP-A from the HDL into the LDL fraction. Recently, Burstein and Caroli (12) isolated a lipoprotein with the electrophoretic mobility of P-globulin but which was nonreactive with antibodies to normal LDL. Since, when delipidized, the lipoprotein moved on paper electrophoresis in the a,-globulin area, they concluded that the abnormal lipoprotein in patients with obstructive jaundice is a "particular" a-LP characterized by a low protein and high lipid content. However, this conclusion, based solely on electrophoretic mobility, has not yet been supported by immunochemical and chemical identification of ApoA.
To study the individual lipoprotein families in LDL fractions from patients with obstructive jaundice, a procedure was developed in our laboratory (13) which permitted the separation of three immunochemically distinct lipoproteins, LP-A, LP-B, and LP-X. Quantitative de- termination showed that the combined LP-X and LP-B accounted for 98%, and the LP-A for only 2%, of the total protein content of LDL fraction.
The purpose of this paper is to present additional evidence that the abnormal lipoprotein, LP-X, with its high content of phospholipid and unesterified cholesterol is primarily responsible for the characteristic lipid and lipoprotein pattern of the plasma and of the LDL fraction in subjects with obstructive jaundice. This evidence is based on (a) differences in the chemical composition, immunochemical properties, and quantitative distribution of LP-A, LP-B, and LP-X, and (b) certain physical, chemical, and immunochemical characteristics of partially and totally delipidized LP-X. A preliminary report de- scribing studies on the identification of the protein moiety of LP-X has appeared (14) .
MATERIALS AND METHODS
Blood samples were obtained from four patients with extrahepatic biliary obstruction and from two patients with intrahepatic biliary obstruction. The diagnoses were established by the standard laboratory tests, liver biopsy, and surgical procedures. Blood drawn after an overnight fast was collected in plastic bags containing 2.2% Na citrate (Fenwal Laboratory, Morton Grove, Ill., and the plasma was recovered by low-speed centrifugation at room temperature. Isolation and separation of lipoproteins. The separation scheme including the partial and total delipidization of LP-X is outlined in Fig. 1 . The VLDL were obtained by layering plasma samples under equal volumes of NaCl solution (d 1.006 g/ml) and by centrifuging in the Type Ti 50 rotor of the Spinco Model L-2 ultracentrifuge (Beckman Instruments, Inc., Fullerton, Calif.) for 22 hr at 105,000 g and 4VC. The top fraction (d < 1.006 g/ml) containing VLDL was removed by a tube-slicing technique, resuspended in 3 vol of 1.006 g/ml NaCl solution, and recentrifuged under identical conditions. This washing procedure was repeated three times to remove traces of albumin. The LP-B, LP-X, and HDL were isolated from the bottom fraction (d > 1.006 g/ml) by a previously described procedure which combines heparin precipitation, ethanol fractionation, and ultracentrifugation (13) . The isolated LP-B and LP-X fractions were resuspended in NaCl solution (1.063 g/ml) and the HDL in the NaCl-KBr solution (1.210 g/ml) and recentrifuged at 105,000 g for 44 hr. This washing procedure was repeated several times until lipoprotein fractions were free of albumin, as demonstrated by immunodiffusion tests.
Plasma samples were also fractionated into VLDL, LDL, and HDL by standard sequential preparative ultracentrifugation (4). The partially delipidized LP-C were isolated as described previously (14) .
Lipoprotein fractions, dialyzed exhaustively against distilled water containing 0.05%' EDTA, pH 7.0, were characterized by protein and lipid analyses and by determination of electrophoretic and immunochemical properties.
Partial and total delipidization of lipoproteins. Partial delipidization of purified LP-X fractions was accomplished according to a slight modification of the procedure by Gustafson (15) . The lipoprotein fractions (5-20 mg of protein) were lyophilized in the absence of starch or any other additive, and the dry samples were extracted four times by vigorous shaking with 40 ml of n-heptane, spectranalyzed grade (Fisher Scientific Co., Pittsburgh, Pa.), for 1 hr at 4°. After each treatment with solvent, the partially delipidized lipoprotein was sedimented by low-speed centrifugation for 20 min at 4°C, the n-heptane extract was decanted, and fresh solvent was added. The final sediment was dried under nitrogen and dissolved in 0.15 M NaCl. The solution density was adjusted to 1.21 g/ml by adding KBr, and the mixture was centrifuged at 105,000 g for 44 hr. The top fraction (upper 1 cm) containing the partially delipidized lipoprotein fraction was removed by a tube-slicing technique.
Total delipidization of LP-A, LP-B, and LP-Xpd was performed according to a modification of the procedure of Scanu, Lewis, and Bumpus (16 The purified rabbit antisera to LP-X were prepared and characterized as described previously (13 (23) . The ratio of enzyme to substrate was 1: 80 (w/w). Aliquots of the reaction mixture were taken at various intervals from 0 to 24 hr, and the reaction was stopped by adding 0.1 N HCL. The precipitated protein was removed by low-speed centrifugation, and the supernatant portion was dried in a vacuum desiccator. The residue was dissolved in 0.2 N sodium citrate, pH 2.2, and analyzed on the amino acid analyzer. The blank levels of amino acids and the contribution from autodigestion were determined in separate samples of ApoX and enzyme preparation, respectively. The C-terminal amino acids were determined also by hydrazinolysis according to the procedure by Braun and Schroeder (24) . The qualitative N-terminal amino acid analysis of approximately 1 mg of proteins was carried out using dansyl chloride as described by Gray (25) . The dansylated product was separated from excess reagents and hydrolyzed for 18 hr, and the N-dansyl amino acids were extracted according to the procedure by Gros and Labouesse (26) . The dansylated amino acids were separated on polyamide layers as described by Woods and Wang (27) .
Amiino acid analysis. Samples of ApoA, ApoB, ApoX, and albumin (1-2 mg) were hydrolyzed in constant boiling HCl (1 ml for each milligram of protein) in evacuated, sealed tubes in an oven maintained at 110'C for 24 and 72 hr. The hydrolysate was extracted with chloroform to remove any trace of fatty acids. The aqueous layer was separated, and the HCl was evaporated in vacuo in a rotary evaporator. The residue was then dissolved in 1 ml of 0.2 N sodium citrate buffer, filtered through a fine frit sintered glass filter, and analyzed on a Beckman Model 120C amino acid analyzer according to an accelerated automatic procedure (28) (29) . The values for cysteic acid were corrected for the 94%o recovery found by .
Lipid, protein, and carbohydrate alalyses. Esterified and unesterified cholesterol, triglycerides;'phospholipids, and total protein were determined as described previously (13) . Free fatty acids were determined according to the method of Dole (31) . Quantitative analysis of individual phospholipids was performed by two-dimensional thin layer chromatography as described previously (32 electrophoresis ( Fig. 3 ) and reacted only with antibodies to LP-X. In contrast to agar gel electrophoresis, LP-X moved towards the anode on agarose gel and starch gel.
On starch gel electrophoresis LP-X migrated with a mobility slightly less than that of LP-B (Fig. 4) . The chemical composition of LP-X was characterized by a high content of phospholipid (66.5%), a low content of protein (5.8%), and the presence of cholesterol almost exclusively in unesterified form (93% of total cholesterol) (13) . On the other hand, the phospholipid composition of LP-X (Table I) 2. The preferential extraction of lecithin, lysolecithin, and cephalin was reflected in a decreased lecithin: sphingomyelin ratio of LP-Xpd (Table I) . Whereas LP-X showed a single, slowly migrating band in agar (Fig. 3) , agarose, and starch gel (Fig. 4 ) electrophoresis, and a single immunoprecipitin arc with anti-LP-X, the partially delipidized LP-X fraction gave a positive immunoprecipitin reaction not only with antibodies to LP-X, but also with antibodies to albumin (Fig. 5, pattern a) . To separate albumin from the immunochemically characteristic protein of LP-Xpd, the density of the partially delipidized lipoprotein solution was adjusted to 1.21 g/ml and the mixture was centrifuged at 105,000 g for 44 hr (Fig. 1) . The bottom fraction contained immunochemically identified albumin (Fig. 5, pattern b) . LP-X samples showed that albumin accounted for 40% (38-42%) and the nonalbumin moiety for 60% (58) (59) (60) (61) (62) of the total protein content of LP-X.
Characterization of the nonalbumin protein moiety (ApoX) of LP-X. Total delipidization of the albgiminfree LP-Xpd fraction resulted in the isolation of the water-soluble protein moiety, ApoX, which showed three distinct immunoprecipitin arcs in agar-gel electrophoresis (Fig. 6, upper pattern) ; whereas one component migrated toward the anode and the other toward the cathode, the third, a relatively weak immunoprecipitin arc, was located in the middle close to the antigen well. In 7% polyacrylamide electrophoresis the ApoX preparations showed a characteristic pattern consisting of three fast moving bands (Fig. 7, pattern a) and the nonalbumin containing LP-Xpd. Because of a very low content of LP-A in the low density segment of the lipoprotein spectrum, analysis of the amino acid composition of ApoA was performed on a preparation isolated from the corresponding lipoprotein fraction of HDL. The differences between apolipoproteins were reflected primarily in the different content of such amino acids as lysine, aspartic acid, glutamic acid, alanine, isoleucine, and leucine. The values for ApoB agreed well with those reported for ApoB isolated from normal serum (38) (39) (40) . On the other hand, there were some differences in the content of basic amino acids, alanine, and methionine between the ApoA preparation of this study and those preparations reported recently in the literature (40) (41) (42) (43) . It has been suggested (43) that the discrepancy in the results of amino acid composition of ApoA preparations from various laboratories may be due to a varying degree of lipoprotein heterogeneity in the HDL spectrum of individual plasma donors. The apolipoprotein heterogeneity of serum and chyle HDL has been established by our studies (44) (45) indicating the presence of ApoB, and by Shore and Shore (46) (47) who have demonstrated that ApoA consists of two nonidentical polypeptides. Although a characteristic amino acid composition of ApoA from patients with obstructive jaundice cannot be excluded by these preliminary experiments, the immunochemical behavior of ApoA was identical with that of an ApoA preparation from a normal subject. The main characteristic of the amino acid composition of ApoX is the absence of cystine and cysteine and a relatively low content of histidine; no cysteic acid was detected after performic acid oxidation of ApoX. The difference between the amino acid composition of ApoX and the "obstructive lipoprotein" (OLP) isolated by Switzer (7) was, in all probability, due to the presence of albumin in the totally delipidized OLP preparation. The qualitative N-terminal amino acid analysis of ApoX showed the presence of dansylated serine and threonine as the major terminal amino acids; aspartic and glutamic acids were present in trace amounts. The results of a time study of the carboxypeptidase A digestion of ApoX are presented in Fig. 8 . The release of major C-terminal amino acids alanine and valine in an approximate molar ratio of 2: 1 seemed to level off after 7 hr of digestion. Other amino acids liberated after 24 hr, not shown in Fig. 8 , include, in decreasing molar amounts, threonine, aspartic acid, glutamic acid, tyrosine, phenylalanine, glycine, and isoleucine. There were no additional amino acids released by the action of carboxypeptidase B. In a separate experiment, the action of carboxypeptidase A on ApoX for 1 min at 250C resulted in the release of alanine in a molar ratio of 10: 1 over valine. After hydrazinolysis of ApoX several amino acids could be detected by chromatography; alanine, glutamic acid, and valine were detected in decreasing or- der as the major amino acids, while serine, aspartic acid, and glycine were present in trace amounts. Although additional quantitative studies will be required, results of these analyses indicate that alanine is the major and valine and glutamic acid the minor C-terminal amino acids of ApoX.
The evidence for an immunochemical similarity, if not identity, between the partially delipidized nonalbumin protein moiety of LP-X and a partially or totally delipidized LP-C, isolated from VLDL of patients with "mixed type" hypertriglyceridemia, has already been presented in a preliminary communication (14) . Recent studies on the characterization of ApoC provided additional evidence for a close relationship between this apolipoprotein and ApoX. Similarly to ApoX, the ApoC gave three distinct immunoprecipitin lines with antibodies to LP-X in 1% agar electrophoresis (Fig. 6 , lower pattern) and displayed three fast moving bands in 7% polyacrylamide electrophoresis (Fig. 7, pattern b) . A fourth, poorly stainable band close to the stacking gel was identified by immunochemical reaction with antibodies to LP-X. The ApoX and ApoC gave a complete fusion of immunoprecipitin lines with antibodies to LP-X and VLDL (Fig. 9 ).
DISCUSSION
The low density lipoprotein pattern in biliary obstruction is characterized almost exclusively by the presence of the immunochemically distinct lipoprotein families LP-B and LP-X (7, 12, 13 (58) . However, despite this high binding capacity of ApoX, it is possible that albumin plays an important role in maintaining the structural integrity of a lipoprotein particle characterized by a phospholipid: protein ratio of 11-12. In comparison, the next highest value known for the phospholipid: protein ratio of a lipoprotein is the relatively low value of 4.7, determined for a Sf > 5000 chylomicron fraction (58) . Since albumin derived from LP-X contained free fatty acids and an unidentified phospholipid, presumably lysolecithin, the LP-X and albumin may be interwoven into a structural entity through both lipid-lipid and protein-protein interactions. The relatively high degree of structural orderliness for a macromolecule consisting of noncovalently linked constituents is illustrated indirectly, but significantly, by excellent agreement among several laboratories regarding the per cent composition of protein and lipid components and by a constant ratio of albumin and ApoX of isolated LP-X preparations. The intriguing questions about the molecular arrangement in the albumin-LP-X complex, the site of its formation and the reasons for its apparently exclusive occurrence in patients with obstructive jaundice (13) (19) and in all density lipoprotein classes isolated from plasma of normal, fasting men (60) . The distribution studies have shown (32, 61 ) that ApoC appears to be present in highest amounts in VLDL of subjects with mixed type hypertriglyceridemia. Although the demonstration of ApoC as a separate apolipoprotein had been accepted initially with certain skepticism (48, 62, 63) , the results of recent studies from two laboratories have fully confirmed its occurrence in human plasma lipoproteins. Brown, Levy, and Fredrickson (64) confirmed that phospholipid-protein residues isolated from human plasma VLDL reacted not only with antibodies to HDL and LDL, but gave also at least one specific immunoprecipitin line with antibodies to VLDL. Moreover, these authors were able to fractionate the soluble portion of totally delipidized VLDL on Sephadex G-100 column into two major fractions. One fraction contained primarily ApoA, whereas the second fraction consisted of a mixture of peptides differing in the electrophoretic mobility and N-terminal amino acids. Further fractionation of this mixture on DEAE-cellulose column resulted in the isolation of four fractions (D1-D4), two of which were characterized by N-terminal serine and C-terminal alanine (D3 and D4) and one by N-terminal threonine and C-terminal valine (Di). Very recently, the same authors characterized fraction D2 by N-terminal threonine and C-terminal glutamic acid (65) . Shore and Shore (66) isolated from VLDL and HDL2 a polypeptide characterized by alanine as C-terminal amino acid. Results of recent studies in this laboratory have shown that ApoC isolated from plasma VLDL (14, 67) and characterized by serine and threonine as N-terminal amino acids, contained alanine as the major C-terminal amino acid. The ApoC was resolved in 7% polyacrylamide gel electrophoresis into three very characteristic fast moving bands and a weak band close to the stacking gel; however, some preparations showed additional weak bands. Immunochemical characterization of LP-C has shown (68) that the protein moiety consists of at least three antigenic determinants. On the basis of all these experiments, we suggest that ApoC is a distinct human plasma apolipoprotein, the quaternary structure of which is composed of nonidentical polypeptides characterized by a high affinity for lipid binding. Although additional studies are essential for establishing the number and properties of constitutive ApoC polypeptides, it seems clear that ApoC contains three well characterized polypeptides (N-terminal serine and C-terminal alanine; N-terminal threonine and C-terminal valine; and N-terminal threonine and C-terminal glutamic acid) and, possibly, two additional polypeptides; it is easily detectable by its characteristic behavior in 7% polyacrylamide gel electrophoresis and, in its totally delipidized form, by three distinguishable antigenic determinants.
The possible identity of ApoX with ApoC is based on following evidence: (a) similarity of the electrophoretic patterns in different supporting media such as agar, agarose, and polyacrylamide gels, (b) similarity of phospholipid: protein ratios of LP-X and LP-C delipidized under identical conditions, (c) identical N-terminal (threonine and serine) and C-terminal (alanine, valine, and glutamic acid) amino acids, and (d) complete fusion of ApoX and ApoC precipitin lines in reaction with antibodies to VLDL (LP-C) or LP-X. Although only a complete chemical characterization and analysis of quaternary structure or polypeptide composition of both ApoX and ApoC will provide the final proof, we propose a chemical identity of these two apolipoproteins as the most plausible working hypothesis.
A C KNOWLEDGMENT'S We wish to thank Doctors J. D. Welsh and R. E. Ringrose for providing us with serum samples from patients under their care on the medical services of the University of Oklahoma Medical Center, Oklahoma City. We thank Mrs. S. L. Walraven and Mr. M. Bates for their technical assistance and Mrs. M. Farmer for her help in the preparation of the manuscript.
D. Seidel was supported by U. S. Public Health Service General Research Support Grant FRO 5538. These studies were supported in part by Grants HE-6221, HE-7005, and HE-2528 from the U. S. Public Health Service, and by the Oklahoma Heart Association.
